stella
beta
Prevention of Post-TIPS Hepatic Encephalopathy by Administration of Rifaximin and Lactulose — Stella
Recruiting
Back to Hepatic Encephalopathy trials
Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.
Trial locations
(6 sites)
Belgium
Universitaire Ziekenhuizen Leuven, Leuven
Netherlands
Academic Medical Centre, Amsterdam
University Medical Center Groningen, Groningen
Leiden University Medical Center, Leiden
Radboud University, Nijmegen
Show all 6 locations
View full record on ClinicalTrials.gov